...
search icon
bhvn-img

Biohaven Ltd. Share Price

BHVN
NYQ
$10.8
-$0.6
(-5.26%)
1D
Industry: Biotechnology Sector: Health Care

Biohaven Ltd. Analyst Forecast

Biohaven Ltd. Share Price Chart

Biohaven Ltd. Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.72B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.04M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
3.31
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$7.48 L
$18.57 H
$10.8

About Biohaven Ltd., Common Stock

Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which is in Phase 2 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in Phase 2 clinical trial for treating IgA nephropathy; BHV-1600, which is in Phase 1 clinical trial for the treatment of peripartum cardiomyopathy; BHV-8000 that is in Phase 3 clinical trial for treating Parkinson's disease; Opakalim, which is in Phase 3 clinical trial for the treatment of focal epilepsy; BHV-2100 that is in Phase 2 clinical trial for the treatment of pain disorders; and BHV-2000, which is in Phase 2 clinical trial for treating obesity. The company is also developing BHV-1510 that is in Phase 2 clinical trial for the treatment of advanced or metastatic epithelial tumors; and BHV-1530, which is in Phase 2 clinical trial for treating urothelial cancer and other tumors. In addition, its preclinical product pipeline includes BHV-1310 for treating myasthenia gravis; BHV-1320 for treating immune mediated-diseases; BHV-1450 for treating Pemphigus, MuSK MG, and LGI-1 Encephalitis; BHV-1420 for treating membranous nephropathy; BHV-1440 for treating Graves' disease and TED; BHV-6500 for treating type 1 diabetes; BHV-1490 for treating IgM neuropathy and Waldenstrom's; BHV-8100 for treating neurodegenerative diseases; and BHV-1955 for treating tinnitus. The company was formerly known as Biohaven Research Ltd. and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut. more

Industry: BiotechnologySector: Health Care

Biohaven Ltd. Stock Returns

Time FrameBHVNSectorS&P500
1-Week Return-1.91%1.75%0.08%
1-Month Return11.23%4.67%4.62%
3-Month Return4.75%-1.19%11.05%
6-Month Return13.09%-0.77%10.4%
1-Year Return-33.33%14.25%27.7%
3-Year Return-50.12%16.28%77.34%
5-Year Return47.95%24.12%79.32%

Biohaven Ltd. Financials

Dec '21Dec '22Dec '23Dec '24Dec '255YR TREND
Total Revenue462.51M----[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Cost of Revenue1.39M1.39M3.37M3.92M4.14M[{"date":"2021-12-31","value":33.65,"profit":true},{"date":"2022-12-31","value":33.48,"profit":true},{"date":"2023-12-31","value":81.38,"profit":true},{"date":"2024-12-31","value":94.76,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Gross Profit370.85M(1.39M)(3.37M)(3.92M)(4.14M)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.37,"profit":false},{"date":"2023-12-31","value":-0.91,"profit":false},{"date":"2024-12-31","value":-1.06,"profit":false},{"date":"2025-12-31","value":-1.12,"profit":false}]
Gross Margin80.18%----[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Operating Expenses218.90M567.93M436.05M885.11M741.24M[{"date":"2021-12-31","value":24.73,"profit":true},{"date":"2022-12-31","value":64.17,"profit":true},{"date":"2023-12-31","value":49.27,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":83.75,"profit":true}]
Operating Income(218.90M)(567.93M)(436.05M)(885.11M)(745.38M)[{"date":"2021-12-31","value":-21890000000,"profit":false},{"date":"2022-12-31","value":-56793200000,"profit":false},{"date":"2023-12-31","value":-43605100000,"profit":false},{"date":"2024-12-31","value":-88511100000,"profit":false},{"date":"2025-12-31","value":-74537800000,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Pre-Tax Income(212.43M)(569.84M)(409.55M)(845.69M)(737.38M)[{"date":"2021-12-31","value":-21243000000,"profit":false},{"date":"2022-12-31","value":-56984100000,"profit":false},{"date":"2023-12-31","value":-40955100000,"profit":false},{"date":"2024-12-31","value":-84568700000,"profit":false},{"date":"2025-12-31","value":-73738000000,"profit":false}]
Income Taxes1.37M438.00K(1.38M)735.00K1.44M[{"date":"2021-12-31","value":94.73,"profit":true},{"date":"2022-12-31","value":30.37,"profit":true},{"date":"2023-12-31","value":-95.91,"profit":false},{"date":"2024-12-31","value":50.97,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Income After Taxes-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Income From Continuous Operations(848.40M)(570.28M)(408.17M)(846.42M)(738.82M)[{"date":"2021-12-31","value":-84839600000,"profit":false},{"date":"2022-12-31","value":-57027900000,"profit":false},{"date":"2023-12-31","value":-40816800000,"profit":false},{"date":"2024-12-31","value":-84642200000,"profit":false},{"date":"2025-12-31","value":-73882200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income(213.80M)(570.28M)(408.17M)(846.42M)(738.82M)[{"date":"2021-12-31","value":-21379600000,"profit":false},{"date":"2022-12-31","value":-57027900000,"profit":false},{"date":"2023-12-31","value":-40816800000,"profit":false},{"date":"2024-12-31","value":-84642200000,"profit":false},{"date":"2025-12-31","value":-73882200000,"profit":false}]
EPS (Diluted)(13.08)(14.25)(5.66)(9.15)(6.65)[{"date":"2021-12-31","value":-1308,"profit":false},{"date":"2022-12-31","value":-1425,"profit":false},{"date":"2023-12-31","value":-566,"profit":false},{"date":"2024-12-31","value":-915,"profit":false},{"date":"2025-12-31","value":-665,"profit":false}]

Biohaven Ltd. Ratios

Biohaven Ltd. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

BHVN
Cash Ratio 6.68
Current Ratio 7.41

Biohaven Ltd. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BHVN
ROA (LTM) -83.38%
ROE (LTM) -333.00%

Biohaven Ltd. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BHVN
Debt Ratio Lower is generally better. Negative is bad. 0.72
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.28

Biohaven Ltd. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BHVN
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 13.25
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Biohaven Ltd. share price today?

Biohaven Ltd. (BHVN) share price today is $10.8

Can Indians buy Biohaven Ltd. shares?

Yes, Indians can buy shares of Biohaven Ltd. (BHVN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BHVN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Biohaven Ltd. be purchased?

Yes, you can purchase fractional shares of Biohaven Ltd. (BHVN) via the Vested app. You can start investing in Biohaven Ltd. (BHVN) with a minimum investment of $1.

How to invest in Biohaven Ltd. shares from India?

You can invest in shares of Biohaven Ltd. (BHVN) via Vested in three simple steps:

  • Click on Sign Up or Invest in BHVN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Biohaven Ltd. shares
What is Biohaven Ltd. 52-week high and low stock price?

The 52-week high price of Biohaven Ltd. (BHVN) is $18.57. The 52-week low price of Biohaven Ltd. (BHVN) is $7.48.

What is Biohaven Ltd. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Biohaven Ltd. (BHVN) is

What is Biohaven Ltd. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Biohaven Ltd. (BHVN) is 13.25

What is Biohaven Ltd. dividend yield?

The dividend yield of Biohaven Ltd. (BHVN) is 0.00%

What is the Market Cap of Biohaven Ltd.?

The market capitalization of Biohaven Ltd. (BHVN) is $1.72B

What is Biohaven Ltd.'s stock symbol?

The stock symbol (or ticker) of Biohaven Ltd. is BHVN

How Can Investors Use Biohaven Ltd. Share Price Data for Long-Term Investment Decisions?

Consider the share price of Biohaven Ltd. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Biohaven Ltd. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Biohaven Ltd. shares for Indian investors?

When investing in Biohaven Ltd. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Biohaven Ltd. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Biohaven Ltd. share price with other stocks in the same sector?

Rather than merely checking the share price of Biohaven Ltd. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Biohaven Ltd. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top